Filing Details
- Accession Number:
- 0001410939-22-000120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 17:37:37
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-05 17:37:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Iveric Bio Inc. | ISEE | Pharmaceutical Preparations (2834) | 208185347 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1696429 | Keith Westby | C/O Iveric Bio, Inc. 8 Sylvan Way Parsippany NJ 07054 | Svp & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-01 | 10,030 | $22.96 | 59,759 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 5,199 | $10.03 | 64,958 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-12-02 | 5,199 | $10.03 | 5,199 | $10.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-12-29 | No | 4 | M | Direct |
Footnotes
- The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $22.62 to $23.84 per share on December 1, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
- This total includes 661 shares acquired by the Reporting Person on September 15, 2022 under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
- This option was granted on December 29, 2012 and is currently excisable for all shares underlying the option.
Billionaire Hedge Funds
